半胱氨酰白三烯受体1在胰腺癌组织中的表达及临床意义

孟艳; 朱莹; 张亚庆; 邹凌云; 张秋楠

doi:10.3969/j.issn.1001-5256.2017.01.029

半胱氨酰白三烯受体1在胰腺癌组织中的表达及临床意义

DOI: 10.3969/j.issn.1001-5256.2017.01.029

1. 葫芦岛市中心医院龙湾院区急诊科
2. 葫芦岛市中心医院消化科

详细信息

中图分类号: R735.9
计量
- 文章访问数: 2399
- HTML全文浏览量: 50
- PDF下载量: 443
- 被引次数: 0
出版历程
- 出版日期: 2017-01-20

Expression of cysteinyl leukotriene receptor-1 in pancreatic cancer tissue and its clinical significance

Emergency Department, Longwan Branch of Central Hospital of Huludao, Huludao, Liaoning 125001, China

摘要

摘要:
目的探讨半胱氨酰白三烯受体（Cys LTR）1在胰腺癌组织中的表达及其与临床特征和预后的关系。方法选取2015年1月-10月葫芦岛中心医院收治的病理确诊为胰腺癌的患者42例,收集癌组织及癌旁组织,采用real-time PCR检测组织Cys LTR-1 mRNA相对表达量,并对患者随访1年。计量资料两组间比较采用t检验;多组间比较采用方差分析,进一步两两比较采用LSD-t检验。胰腺癌患者预后的影响因素采用多因素logistic回归分析。结果癌组织中Cys LTR-1 mRNA相对表达量高于癌旁组织,差异有统计学意义（0.037 1±0.020 5 vs 0.016 8±0.011 4,t=6.58,P<0.001）;Cys LTR-1 mRNA相对表达量与患者的TNM分期（t=2.731,P=0.009）、分化程度（F=10.537,P<0.001）和淋巴结转移相关（t=3.408,P=0.002）。随访期内死亡17例,存活25例;死亡患者Cys LTR-1 mRNA相对表达量高于存活患者（0.045 6±0.021 7 vs 0.031 3±0.019 8）,差异有统计学...
- 胰腺肿瘤 /
- 受体,白三烯 /
- 肿瘤标记,生物学
Abstract:
Objective To investigate the expression of cysteinyl leukotriene receptor- 1( Cys LTR- 1) in pancreatic cancer tissue and its association with clinical features and prognosis. Methods A total of 42 patients with pathologically confirmed pancreatic cancer who were admitted to Central Hospital of Huludao from January to October,2015 were enrolled,and cancer and adjacent tissues were collected. Real-time PCR was used to measure the relative mRNA expression of Cys LTR- 1 in these tissues,and the patients were followed up for 1 year.The t- test was used for comparison of continuous data between groups; an analysis of variance was used for comparison between multiple groups,and the least significant difference t- test was used for comparison between any two groups. The multivariate logistic regression analysis was used to determine influential factors for the prognosis of patients with pancreatic cancer. Results The cancer tissues had significantly higher relative mRNA expression of Cys LTR- 1 than adjacent tissues( 0. 037 1 ± 0. 020 5 vs 0. 016 8 ± 0. 011 4,t = 6. 58,P<0. 001). The relative mRNA expression of Cys LTR- 1 was associated with TNM stage( t = 2. 731,P = 0. 009),degree of tumor differentiation( F = 10. 537,P < 0. 001),and lymph node metastasis( t = 3. 408,P = 0. 002). During the 1- year follow- up,17 patients died and25 survived; the patients who died had significantly higher relative mRNA expression of Cys LTR- 1 than those who survived( 0. 045 6 ±0. 021 7 vs 0. 031 3 ± 0. 019 8,t = 2. 21,P = 0. 03). The logistic regression analysis showed that TNM stage( OR = 6. 92,95% CI: 1. 30-36. 82,P = 0. 02),degree of tumor differentiation( OR = 5. 71,95% CI: 1. 44- 22. 62,P = 0. 01),and lymph node metastasis( OR =9. 62,95% CI: 2. 23- 41. 46,P < 0. 001) were prognostic factors for pancreatic cancer. After adjustment for age,sex,TNM stage,degree of tumor differentiation,tumor location,and lymph node metastasis,the mRNA expression of Cys LTR- 1 was still a prognostic factor for patients with pancreatic cancer( OR = 1. 11,95% CI: 1. 07- 1. 15,P = 0. 03). Conclusion Cys LTR- 1 is involved in the development and progression of pancreatic cancer and can be used as a new molecular marker for prognostic evaluation in patients with pancreatic cancer.
- pancreatic neoplasms /
- receptors /
- leukotriene

HTML全文

参考文献(13)

[1]GBD 2013 Mortality and Causes of Death Collaborators.Global,regional,and national age-sex specific all-cause and cause-specific mortality for 240 causes of death,1990-2013:a systematic analysis for the Global Burden of Disease Study 2013[J].Lancet,2015,385(9963):117-171.

[2]CHEN W,ZHENG R,BAADE PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.

[3]CONROY T,BACHET JB,AYAV A,et al.Current standards and new innovative approaches for treatment of pancreatic cancer[J].Eur J Cancer,2016,57:10-22.

[4]ZAMBIRINIS CP,PUSHALKAR S,SAXENA D,et al.Pancreatic cancer,inflammation,and microbiome[J].Cancer J,2014,20(3):195-202.

[5]PU J,LI X,ZHU J,et al.Expression and roles of poly(ADP-ribose)polymerase-1 and caspase-3 in pancreatic cancer and adjacent tissues[J].J Clin Hepatol,2016,32(2):337-341.(in Chinese)蒲竞,李汛,朱骏,等.PARP-1和caspase-3在胰腺癌及癌旁组织中的表达及意义[J].临床肝胆病杂志,2016,32(2):337-341.

[6]SAVARI S,VINNAKOTA K,ZHANG Y,et al.Cysteinyl leukotrienes and their receptors:bridging inflammation and colorectal cancer[J].World J Gastroenterol,2014,20(4):968-977.

[7]JIANG KR,HU H,MIAO Y.Value of artery resection in pancreatic cancer surgery[J].J Clin Hepatol,2016,32(5):826-829.(in Chinese)蒋奎荣,胡浩,苗毅.联合动脉切除在胰腺癌手术中的价值[J].临床肝胆病杂志,2016,32(5):826-829.

[8]YANG YM.Highlights and diffculties in surgical treatment for pancreatic cacinoma[J].Chin J Dig surg,2015,14(8):612-614.(in Chinese)杨尹默.胰腺癌外科治疗的热点与难点[J].中华消化外科杂志,2015,14(8):612-614.

[9]HENNIG R,DING XZ,TONG WG,et al.5-Lipoxygenase and leukotriene B(4)receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue[J].Am J Pathol,2002,161(2):421-428.

[10]WANG X,LIU W,HAN YW,et al.Significance of cysteinyl leukotriene receptor in breast cancer[J].Chin J Clin Oncol,2012,39(20):1522-1526.(in Chinese)王欣,刘伟,韩芸蔚,等.半胱氨酰白三烯受体在乳腺癌组织中的表达及意义[J].中国肿瘤临床,2012,39(20):1522-1526.

[11]ZHANG SQ,TANG CB,CHEN WH.Expression of Cys LT1R in colorectal carcinoma tissues and its clinical significance[J].J Shanxi Med Univ,2014,45(3):177-179.(in Chinese)张世强,唐采白,陈卫花.半胱氨酰白三烯受体Cys LT1R在大肠癌组织中的表达及临床意义[J].山西医科大学学报,2014,45(3):177-179.

[12]MEZHYBOVSKA M,WIKSTROM K,OHD JF,et al.The inflammatory mediator leukotriene D4 induces beta-catenin signaling and its association with antiapoptotic Bcl-2 in intestinal epithelial cells[J].J Biol Chem,2006,281(10):6776-6784.

[13]DING X,ZHU C,QIANG H,et al.Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors[J].Biomed Pharmacother,2011,65(7):486-490.

施引文献

资源附件(0)

访问统计